@prefix this: <http://purl.org/np/RAI15S8HNzrrusLdDaKuLpxco4bkol9nrPcKj_xHCKOy8> .
@prefix sub: <http://purl.org/np/RAI15S8HNzrrusLdDaKuLpxco4bkol9nrPcKj_xHCKOy8#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  
  sub:version prov:value "1"^^xsd:integer .
  
  rdf:object ns1:C0006802 "CMR";
    ns1:C0021368 "inflammation";
    ns1:C0026820 "contractile";
    ns1:C0205210 "clinical";
    ns1:C0229671 "serum";
    ns1:C0237820 "recovery";
    ns1:C0277785 "dysfunction";
    ns1:C0301630 "reduction";
    ns1:C0392756 "reduction";
    ns1:C0456962 "rapid";
    ns1:C0522501 "marked";
    ns1:C1293152 "reduction";
    ns1:C1546774 "serum";
    ns1:C1550100 "serum";
    ns1:C1555688 "recovery";
    ns1:C1705938 "based";
    ns1:C1706089 "marked";
    ns1:C2004454 "recovery";
    ns1:C2986411 "improvement";
    ns1:C3272565 "clinical";
    ns1:C3887504 "dysfunction";
    ns1:C3887505 "dysfunction";
    ns1:C4050307 "CMR";
    ns1:C4050308 "CMR";
    ns1:C4551656 "reduction" .
  
  rdf:predicate ns2:TRIPLE_UID:ezgtl5fj-TRIPLE-ABSTRACT-1 "result" .
  
  rdf:subject ns1:C0011777 "dexamethasone";
    ns1:C0087111 "Treatment";
    ns1:C0245109 "anakinra";
    ns1:C1522428 "recombinant interleukin-1";
    ns1:C1533734 "Treatment";
    ns1:C1705169 "Treatment";
    ns1:C3161471 "Treatment";
    ns1:C3538994 "Treatment";
    ns1:C3887704 "Treatment";
    ns1:C4543207 "receptor antagonist";
    ns1:C4721408 "receptor antagonist";
    ns1:C5399721 "receptor antagonist" .
  
  rdfs:Triple-UID ns3:TRIPLE_UID:ezgtl5fj-TRIPLE-ABSTRACT-1 "ezgtl5fj-TRIPLE-ABSTRACT-1" .
  
  rdfs:sentence rdfs:label "Treatment with the recombinant interleukin-1 (IL)-1) receptor antagonist anakinra and dexamethasone resulted in rapid clinical improvement, reduction in serum inflammatory markers and a marked recovery in CMR-based markers of inflammation and contractile dysfunction." .
  
  rdfs:triple rdfs:label "Treatment with the recombinant interleukin-1 ( IL)-1 ) receptor antagonist anakinra and dexamethasone resulted in rapid clinical improvement , reduction in serum inflammatory markers and a marked recovery in CMR - based markers of inflammation and contractile dysfunction" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-07-25T21:47:47.785502"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "gsItPbCyh5MkFvYHgcYXjZpuDNH5gl/5DpdIBw2nTL94DPHErq9+Zv9d077kAQYYJMZCR632fQGF/S9Iik6aCFIoBqf4DOE3z2QbDf/cRB7LUw79/3pto0uBX7DsjXKgsSOOJQ62ihKIwUVoHhv9tweDgUxs6tHBg68aCKYcJ9c=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-07-25T21:47:47.785502"^^xsd:dateTime;
    prov:wasAttributedTo <https://orcid.org/0000-0002-8954-0470> .
}